Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment

Lung cancer (LC) is a highly prevalent and deadly type of cancer characterized by intricate molecular pathways that drive tumor development, metastasis, and resistance to conventional treatments. Recently, ferroptosis, a controlled mechanism of cell death instigated by iron-dependent lipid peroxidat...

Full description

Saved in:
Bibliographic Details
Main Authors: Nadi Rostami Ravari, Farzad Sadri, Mohammad Ali Mahdiabadi, Yaser Mohammadi, Zahra Ourang, Zohreh Rezaei
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2025.1522873/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850231186253676544
author Nadi Rostami Ravari
Farzad Sadri
Farzad Sadri
Mohammad Ali Mahdiabadi
Yaser Mohammadi
Zahra Ourang
Zohreh Rezaei
Zohreh Rezaei
author_facet Nadi Rostami Ravari
Farzad Sadri
Farzad Sadri
Mohammad Ali Mahdiabadi
Yaser Mohammadi
Zahra Ourang
Zohreh Rezaei
Zohreh Rezaei
author_sort Nadi Rostami Ravari
collection DOAJ
description Lung cancer (LC) is a highly prevalent and deadly type of cancer characterized by intricate molecular pathways that drive tumor development, metastasis, and resistance to conventional treatments. Recently, ferroptosis, a controlled mechanism of cell death instigated by iron-dependent lipid peroxidation, has gained attention for its role in LC progression and treatment. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), are emerging as key modulators of ferroptosis, significantly influencing LC biology. This review explores how ncRNAs control ferroptotic pathways and affect tumor growth, metastasis, and therapy resistance in LC. By understanding the dual functions of ncRNAs in both activating and inhibiting ferroptosis, we aim to uncover new therapeutic targets and strategies for LC. These insights provide a promising direction for the development of ncRNA-based treatments designed to induce ferroptosis, potentially improving therapeutic outcomes for patients with LC.
format Article
id doaj-art-3ffd846c2e2a46daaac0d37119a23bf5
institution OA Journals
issn 2296-634X
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj-art-3ffd846c2e2a46daaac0d37119a23bf52025-08-20T02:03:36ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2025-02-011310.3389/fcell.2025.15228731522873Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatmentNadi Rostami Ravari0Farzad Sadri1Farzad Sadri2Mohammad Ali Mahdiabadi3Yaser Mohammadi4Zahra Ourang5Zohreh Rezaei6Zohreh Rezaei7Department of Animal Science Researches, Agriculture and Natural Resources Education and Research Center of Kerman, Agriculture and Natural Resources Education and Research Organization (AREEO), Kerman, IranStudent Research Committee, Birjand University of Medical Sciences, Birjand, IranGeriatric Health Research Center, Birjand University of Medical Sciences, Birjand, IranDepartment of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, IranDepartment of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, IranDepartment of Biochemistry, School of Medicine, Arak University of Medical Sciences, Arak, IranGeriatric Health Research Center, Birjand University of Medical Sciences, Birjand, IranDepartment of Biology, University of Sistan and Baluchestan, Zahedan, IranLung cancer (LC) is a highly prevalent and deadly type of cancer characterized by intricate molecular pathways that drive tumor development, metastasis, and resistance to conventional treatments. Recently, ferroptosis, a controlled mechanism of cell death instigated by iron-dependent lipid peroxidation, has gained attention for its role in LC progression and treatment. Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), are emerging as key modulators of ferroptosis, significantly influencing LC biology. This review explores how ncRNAs control ferroptotic pathways and affect tumor growth, metastasis, and therapy resistance in LC. By understanding the dual functions of ncRNAs in both activating and inhibiting ferroptosis, we aim to uncover new therapeutic targets and strategies for LC. These insights provide a promising direction for the development of ncRNA-based treatments designed to induce ferroptosis, potentially improving therapeutic outcomes for patients with LC.https://www.frontiersin.org/articles/10.3389/fcell.2025.1522873/fullferroptosislung cancernoncoding RNAstherapeutic targetsmetastasis
spellingShingle Nadi Rostami Ravari
Farzad Sadri
Farzad Sadri
Mohammad Ali Mahdiabadi
Yaser Mohammadi
Zahra Ourang
Zohreh Rezaei
Zohreh Rezaei
Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment
Frontiers in Cell and Developmental Biology
ferroptosis
lung cancer
noncoding RNAs
therapeutic targets
metastasis
title Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment
title_full Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment
title_fullStr Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment
title_full_unstemmed Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment
title_short Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment
title_sort ferroptosis and noncoding rnas exploring mechanisms in lung cancer treatment
topic ferroptosis
lung cancer
noncoding RNAs
therapeutic targets
metastasis
url https://www.frontiersin.org/articles/10.3389/fcell.2025.1522873/full
work_keys_str_mv AT nadirostamiravari ferroptosisandnoncodingrnasexploringmechanismsinlungcancertreatment
AT farzadsadri ferroptosisandnoncodingrnasexploringmechanismsinlungcancertreatment
AT farzadsadri ferroptosisandnoncodingrnasexploringmechanismsinlungcancertreatment
AT mohammadalimahdiabadi ferroptosisandnoncodingrnasexploringmechanismsinlungcancertreatment
AT yasermohammadi ferroptosisandnoncodingrnasexploringmechanismsinlungcancertreatment
AT zahraourang ferroptosisandnoncodingrnasexploringmechanismsinlungcancertreatment
AT zohrehrezaei ferroptosisandnoncodingrnasexploringmechanismsinlungcancertreatment
AT zohrehrezaei ferroptosisandnoncodingrnasexploringmechanismsinlungcancertreatment